These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31705249)

  • 1. Prostate MR: pitfalls and benign lesions.
    Chatterjee A; Thomas S; Oto A
    Abdom Radiol (NY); 2020 Jul; 45(7):2154-2164. PubMed ID: 31705249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.
    Kitzing YX; Prando A; Varol C; Karczmar GS; Maclean F; Oto A
    Radiographics; 2016; 36(1):162-75. PubMed ID: 26587887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.
    De Visschere PJ; Vral A; Perletti G; Pattyn E; Praet M; Magri V; Villeirs GM
    Eur Radiol; 2017 May; 27(5):2095-2109. PubMed ID: 27491874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
    Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What You Need to Know Before Reading Multiparametric MRI for Prostate Cancer.
    Walker SM; Choyke PL; Turkbey B
    AJR Am J Roentgenol; 2020 Jun; 214(6):1211-1219. PubMed ID: 32255689
    [No Abstract]   [Full Text] [Related]  

  • 6. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
    Sheridan AD; Nath SK; Aneja S; Syed JS; Pahade J; Mathur M; Sprenkle P; Weinreb JC; Spektor M
    AJR Am J Roentgenol; 2018 May; 210(5):W218-W225. PubMed ID: 29489409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate minimally invasive procedures: complications and normal vs. abnormal findings on multiparametric magnetic resonance imaging (mpMRI).
    Bui TL; Glavis-Bloom J; Chahine C; Mehta R; Wolfe T; Bhatter P; Rupasinghe M; Carbone J; Haider MA; Giganti F; Giona S; Oto A; Lee G; Houshyar R
    Abdom Radiol (NY); 2021 Sep; 46(9):4388-4400. PubMed ID: 33977352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
    Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
    Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
    Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
    J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
    Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
    J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
    Israël B; Leest MV; Sedelaar M; Padhani AR; Zámecnik P; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):469-480. PubMed ID: 31767492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Multiparametric Magnetic Resonance Imaging of the Prostate at 7 T.
    Lagemaat MW; Philips BW; Vos EK; van Uden MJ; Fütterer JJ; Jenniskens SF; Scheenen TW; Maas MC
    Invest Radiol; 2017 May; 52(5):295-301. PubMed ID: 28002239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions.
    van Houdt PJ; Ghobadi G; Schoots IG; Heijmink SWTPJ; de Jong J; van der Poel HG; Pos FJ; Rylander S; Bentzen L; Haustermans K; van der Heide UA
    J Magn Reson Imaging; 2020 Apr; 51(4):1235-1246. PubMed ID: 31588646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central zone lesions on magnetic resonance imaging: Should we be concerned?
    Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
    Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.
    Turkbey B; Mena E; Lindenberg L; Adler S; Bednarova S; Berman R; Ton AT; McKinney Y; Eclarinal P; Hill C; Afari G; Bhattacharyya S; Mease RC; Merino MJ; Jacobs PM; Wood BJ; Pinto PA; Pomper MG; Choyke PL
    Clin Nucl Med; 2017 Oct; 42(10):735-740. PubMed ID: 28806263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?
    Luzzago S; Petralia G; Musi G; Catellani M; Alessi S; Di Trapani E; Mistretta FA; Serino A; Conti A; Pricolo P; Nazzani S; Mirone V; Matei DV; Montanari E; de Cobelli O
    Clin Genitourin Cancer; 2019 Apr; 17(2):88-96. PubMed ID: 30527286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of mpMRI in Benign Prostatic Hyperplasia Assessment and Treatment.
    Walker SM; Turkbey B
    Curr Urol Rep; 2020 Oct; 21(12):55. PubMed ID: 33104969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy.
    Valle LF; Greer MD; Shih JH; Barrett T; Law YM; Rosenkrantz AB; Shebel H; Muthigi A; Su D; Merino MJ; Wood BJ; Pinto PA; Krauze AV; Kaushal A; Choyke PL; Türkbey B; Citrin DE
    Diagn Interv Radiol; 2018; 24(1):46-53. PubMed ID: 29317377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric magnetic resonance imaging for transition zone prostate cancer: essential findings, limitations, and future directions.
    Lewis S; Besa C; Rosen A; Rastinehad AR; Semaan S; Hectors S; Taouli B
    Abdom Radiol (NY); 2017 Nov; 42(11):2732-2744. PubMed ID: 28702787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.